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Systemic Deletion of the Myelin-Associated
Outgrowth Inhibitor Nogo-A Improves Regenerative
and Plastic Responses after Spinal Cord Injury
drocyte myelin glycoprotein (OMgp) (Wang et al., 2002a),
myelin-associated glycoprotein (MAG), and chondroitin
sulfate proteoglycans (Qiu et al., 2000, for review). Anti-
bodies against these CNS myelin proteins enhance re-
generation after spinal cord lesion (Schnell and Schwab,
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Birgit Ledermann,3 Franziska Christ,1,2
Gilles Sansig,4 Herman van der Putten,4
and Martin E. Schwab1,2,*
1Brain Research Institute 1990; Huang et al., 1999; Merkler et al., 2001). Specific
antibodies against Nogo-A increase sprouting of intactUniversity of Zurich
2 Department of Biology Purkinje cells (Buffo et al., 2000), and transgenic expres-
sion of Nogo-A in Schwann cells of peripheral nervesSwiss Federal Institute of Technology Zurich
3 Institute of Laboratory Animal Science delays regeneration of lesioned sciatic nerves (Pot et
al., 2002). All these results indicate that Nogo-A playsUniversity of Zurich
Winterthurerstrasse 190 an important role in limiting axonal regeneration and
plasticity in the CNS.CH-8057 Zurich
Switzerland The nogo gene encodes three major transcripts,
nogo-A, -B, and -C, which are generated by alternative4 Novartis Pharma AG
CH-4002 Basle splicing (Nogo-A/B) or alternative promotor usage
(Nogo-C) (Chen et al., 2000). All three isoforms share aSwitzerland
common C-terminal domain of 188 amino acids (aa)
(Figure 1A), which is also shared with high homology by
the Reticulon family (GrandPre´ et al., 2000). In contrastSummary
to Nogo-A, the Reticulons (Rtn) Rtn1, 2, and 3 are not
expressed by oligodendrocytes and do not exhibit axo-To investigate the role of the myelin-associated pro-
tein Nogo-A on axon sprouting and regeneration in nal growth inhibitory activity (GrandPre´ et al., 2000); their
function so far remains to be elucidated. For a 66 aathe adult central nervous system (CNS), we generated
Nogo-A-deficient mice. Nogo-A knockout (KO) mice domain in the C-terminal part of Nogo-A, -B, and -C
(Nogo-66), a GPI-linked plasma membrane receptor,were viable, fertile, and not obviously afflicted by major
developmental or neurological disturbances. The called NgR, has been identified (Fournier et al., 2001).
NgR mediates not only inhibitory activity of Nogo in vitroshorter splice form Nogo-B was strongly upregulated
in the CNS. The inhibitory effect of spinal cord extract and in vivo (Fournier et al., 2001; GrandPre´ et al., 2002),
but also shows interaction with MAG (Domeniconi et al.,for growing neurites was decreased in the KO mice.
Two weeks following adult dorsal hemisection of the 2002; Liu et al., 2002) and OMgp (Wang et al., 2002a),
suggesting that it is involved in the signaling cascadethoracic spinal cord, Nogo-A KO mice displayed more
corticospinal tract (CST) fibers growing toward and of different growth inhibitory factors. In addition to the
Nogo-66 region, in vitro assays show a strong inhibitoryinto the lesion compared to their wild-type littermates.
CST fibers caudal to the lesion—regenerating and/or activity exerted by a Nogo-A-specific domain upstream
of the common C terminus and the Nogo-66 region (T.sprouting from spared intact fibers—were also found
to be more frequent in Nogo-A-deficient animals. Oertle et al., 2001, Soc. Neurosci., abstract; Prinjha et
al., 2000). A receptor for this site remains to be charac-
terized, but inhibitory effects of this Nogo-A-specificIntroduction
site, of Nogo-66, and of MAG all include rhoA activation
as an obligatory signaling step (Niedero¨st et al., 2002).Lesioned axons do not usually regenerate in the CNS.
However, if peripheral nerves are transplanted into the To study further the role of Nogo-A as an inhibitor of
neuronal regeneration and plasticity, we have generatedbrain or spinal cord, central axons manage to regenerate
over long distances into these implants (Bray et al., knockout (KO) mice, where expression of Nogo-A is
specifically abolished, but Nogo-B and Nogo-C are still1987), whereas cultured peripheral axons strictly refuse
to invade explants of adult CNS tissue, in particular expressed. Following spinal cord lesion, the KO mice
showed an increased number of severed corticospinalCNS white matter (Schwab and Thoenen, 1985). This
observation suggested the presence of specific neurite tract (CST) fibers growing toward and into the lesion
site. Growth of regenerating and/or spared intact fibersgrowth-inhibitory factors in the adult CNS (Caroni and
Schwab, 1988a, 1988b; Schwab and Thoenen, 1985). in the caudal spinal cord was also improved.
Nogo-A was identified as one such inhibitory factor,
expressed in the CNS, particularly in oligodendrocytes Results
(Spillmann et al., 1998; Chen et al., 2000; GrandPre´ et
al., 2000; Prinjha et al., 2000). Several other proteins and Design and Generation of Nogo-A Knockout Mice
proteoglycans with neurite growth-inhibitory activity The nogo gene comprises nine exons and gives rise to
have been identified in CNS myelin, including oligoden- three major protein products (Figure 1A): Nogo-A and
-B by differential splicing and Nogo-C by the use of an
alternative promotor (Chen et al., 2000; Oertle et al.,*Correspondence: schwab@hifo.unizh.ch
5 These authors contributed equally to this work. 2003). To obtain mice where expression of Nogo-A is
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Figure 1. Deletion of the nogo Exons 2 and 3 Results in Abolishment of Nogo-A and Upregulation of Nogo-B in the CNS
(A) Schematic representation of the nogo gene and its major protein products Nogo-A, -B, and -C.
(B) Genomic region covering exons 2 and 3 of the nogo gene and the nogo-A knockout (KO) construct. The PCR screening strategies for the
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selectively abolished, we replaced parts of nogo exons growth and viability were noted. The Nogo-A KO mice
did not show major obvious behavioral alterations as2 and 3 and the intron between them with the PGK-neo
gene (Figure 1B). The resulting construct was used to assessed by a primary neurological screening of the
phenotype (V. Pedersen, unpublished data), nor did theycreate chimeric mice, which were bred with C57BL/6
mice. The heterozygous nogo/ offspring were then show major differences in gross brain anatomy (Figures
2A and 2B) or development of the main fiber tracts,mated with both C57BL/6 and 129/SvJ mice. The off-
spring were genotyped with different PCRs to distin- e.g., the optic nerve or the CST (V. Pedersen and M.E.
Schwab, unpublished data). Likewise, layering of theguish nogo/, nogo/, and nogo/ mice (Figure 1B).
cerebral and cerebellar cortices was regular, and layer
V, including the corticospinal projection neurons, wasExpression Pattern of Nogo in CNS
similar in thickness and appearance in Nogo-A KO miceand Peripheral Tissues
and their wild-type littermates (Figures 2A and 2B). AIn RT-PCR, nogo-A mRNA was not detectable in tissues
more detailed analysis has to await full backcrossingfrom KO mice, whereas in wild-type mice it was found
into pure genetic backgrounds.in all regions of CNS studied (Figure 1C). nogo-B and
nogo-C were expressed in the CNS of both the wild-
type and the KO mice. The nogo-B band was stronger Expression Patterns of Nonneuronal Cellular
in the KO CNS than in wild-type, whereas expression and Extracellular Proteins in CNS Tissue
of nogo-C seemed unchanged (Figure 1C). The mRNA and Oligodendrocyte Cultures
levels of the RTN proteins RTN1, 2, and 3, which show To assess whether the deletion of Nogo-A affects the
homology to the C-terminal 188 aa domain of Nogo-A, expression of other myelin proteins as well as chondroi-
-B, and -C, were not affected by the absence of Nogo-A tin sulfate proteoglycans and glial markers in the spinal
(Figure 1D). cord, immunohistochemical staining for several anti-
At the protein level, Nogo-A was absent in the KO, as gens was performed. Staining for the myelin protein
expected (Figure 1E). The Nogo-A level in the heterozy- MBP (Figures 2C and 2D) revealed no differences in the
gotes was similar to that of wild-type, but Nogo-B levels appearance of the compact myelin. Furthermore, the
were dramatically higher by about 10-folds in the CNS adaxonally localized potential neurite growth inhibitor
of both KO and heterozygous mice (Figure 1E). In con- MAG was present in the inner layer of the myelin sheaths
trast, in the PNS and nonneuronal tissues of KO mice, in KO and wild-type mice (Figures 2E and 2F). Immunhis-
Nogo-B levels were not altered (Figure 1F). Nogo-C pro- tochemical determination of the extracellular matrix
tein levels were not affected (not shown). component chondroitin sulfate proteoglycan (as seen
Immunohistochemistry of brain and spinal cord sec- by the carbohydrate-specific antibody CS-56) revealed
tions confirmed the absence of Nogo-A and the upregu- no differences in perineuronal net formation (Figures 2G
lation of Nogo-B in the Nogo-A KO animals (Figures and 2H, inserts) or axonal expression patterns (Figures
1G and 1H). Double labeling with an antibody for the 2G and 2H) in Nogo-A KO mice.
oligodendrocyte marker CNPase and a Nogo-A-specific The markers for activated microglia (FA/11) and
antiserum (AS472) (Chen et al., 2000) showed the local- astrocytes (GFAP) revealed that neither an alteration
ization of Nogo-A in oligodendrocytes in the wild-type in macrophages/microglia nor astrocytes accompanies
animals, whereas the Nogo-A-specific signal was lack- the deficit in Nogo-A (Figures 2I–2L) in the unlesioned
ing in the KO oligodendrocytes (Figure 1G). In contrast, spinal cord.
an antiserum that recognizes Nogo-A/B (Bianca) de- Immunolabeling of oligodendrocyte-enriched glial cell
tected more Nogo-B in the KO oligodendrocytes as cultures from C57BL/6 wild-type and Nogo-A KO mice
compared with the wild-type (Figure 1H), indicating that for maturation-specific markers revealed no obvious dif-
the upregulation of Nogo-B occurs predominantly in oli- ferences in oligodendrocytes and their progenitors in
godendrocytes. size or processes or membrane sheet morphology (Fig-
ures 3A–3D) as determined by staining for O4 and GalC.
Furthermore, mature oligodendrocytes of Nogo-A KOViability, Behavior, and Gross CNS Anatomy
of Knockout Mice mice stained for MAG and MOG were morphologically
indistinguishable from wild-type oligodendrocytes (notNogo-A KO mice were viable and fertile; no differences
between KO, heterozygous, and wild-type pups in shown).
transfected embryonic stem cells and for the mice are shown, as well as the expected PCR products from nogo-A wild-type (wt), heterozygous
(HT), and KO mice. Primers A, B, I, and J were used to screen the transfected ES cells. For genotyping the mice, all five PCR reactions were
performed.
(C and D) RT-PCR showing the expression of different Nogo variants (C) and other reticulon members (D) in nogo-A wild-type and KO mice,
with -actin as a control. Genomic mouse DNA and water were used as controls for each primer pair (not shown).
(E and F) Immunoblotting with AS Bianca showing the expression of Nogo-A and Nogo-B in nogo-A wild-type, KO, and heterozygous mice
in CNS tissues (E) and in non-CNS tissues (F). In (E), about 8 g of total protein were loaded in each lane for KO and wt, and about 15 g
for HT; in (F) loading was 5 g. Molecular weight markers are indicated on the left. In (E) and (F), Nogo-A and Nogo-B are detected on the
same blot and with the same exposure time. BS, brain stem; C, cortex; CB, cerebellum; HC, hippocampus; S, striatum; SC, spinal cord.
(G) Immunofluorescence double staining of spinal cord white matter for the oligodendrocyte marker CNPase (green) and Nogo-A (red); AS472
shows absence of Nogo-A in KO white matter and oligodendrocytes.
(H) Double immunofluorescence for Nogo-A/B (red; AS Bianca) in spinal cord white matter with CNPase (green) depicting the upregulation of
Nogo-B in the white matter of Nogo-A KO mice. Scale bar equals 8 m.
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Figure 2. Gross Adult Brain Anatomy and Immunofluorescence for Myelin and Glial Markers in Wild-Type and Nogo-A Knockout Mice
(A and B) Nogo-A wild-type and KO adult forebrain (A) and cerebellum (B) frontal sections depicting gross anatomy of the cortical and
subcortical regions and the regular laminar structure of the cerebral and cerebellar cortices (inserts). II–VI, layers II–VI of the parietal isocortical
areas of the hindlimb/forelimb motor cortex; 3V, third ventricle; 4V, fourth ventricle; 6, 8, 9, 10Cb, sixth, eighth, ninth, tenth cerebellar lobule;
CA, corpus ammonis; CPu, caudate putamen; Crus 1/2, Crus 1/2 of ansiform lobule; LV, lateral ventricle; PM, paramedian lobule (according
to Zilles and Wree, 1994; Paxinos and Franklin, 2001). Scale bars equal 160 mm in (A) and (B), 83 m in insert to (A), and 42 m in insert to (B).
(C–N) Immunofluorescence staining for myelin basic protein (MBP) (C and D), MAG (E and F), chondroitin sulfate proteoglycan (antibody CS-
56) (G and H), the astrocyte marker GFAP (I and J), and the marker for activated microglia FA/11 (K and L) and Nogo-A (M and N) in Nogo-A
wild-type and KO adult spinal cord white matter, analyzed by confocal laser scanning microscopy. Scale bars equal 8 m in the main images
and 35 m in the inserts.
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Figure 3. KO Oligodendrocytes In Vitro and Myelin Ultrastructure In Vivo Does Not Differ from that of Wild-Type Mice, but KO Spinal Cord
Membrane Protein Extract Shows Drop of Neurite Growth Inhibitory Activity
(A–D) Immunolabeling of oligodendrocytes for the early stage marker O4 (A and B) and the myelin glycolipid GalC (C and D). Scale bars equal
8 m.
(E and F) Transmission electron micrographs show normal periodicity and no decompaction of myelin sheaths in CNS myelin of the optic
nerve of Nogo-A KO (E) versus wild-type (F) mice. Scale bar equals 420 nm in main images and 90 nm in inserts.
(G–K) P6 rat cerebellar granule cells plated on adult mouse spinal cord membrane protein (CHAPS) extract (15 g/cm2 ) were cultured for 24
hr, fixed, and stained with the neurite marker MAB 1b. Neurite growth was increased on KO as compared to wt extract. A monoclonal Ab
against Nogo-A (11C7 Fab) increased outgrowth on wt extract. Values shown in (K) are means  SEM of four experiments. Scale bar equals
75 m.
Inhibitory Activity and Ultrastructure structural morphology of optic nerve axons was indistin-
guishable between the two genotypes.of Knockout Myelin
Inhibitory activity for neurite outgrowth of spinal cord
membrane protein extracts from adult KO and wild-type Axonal Regeneration and Plasticity
The qualitative evaluation of the spinal cord lesion sitesmice was determined using newborn rat dissociated
cerebellar granule cells on protein-coated culture revealed that the left and right main dorsomedial CSTs
in the dorsal funiculi were transected completely in alldishes. On wild-type spinal cord extracts, neurite growth
was poor (Figures 3G and 3K). A monoclonal antibody animals as well as large parts of the gray matter. Part
of the lateral white matter was spared by the lesion,against the Nogo-A-specific region (mAB 11C7 Fab) sig-
nificantly increased neurite outgrowth (Figures 3H, 3I, often leaving a few fibers of the dorsolateral CST intact
and providing tissue bridges for regenerating CST fibers.and 3K). An identical increase was seen on a substrate
of membrane protein extract of KO spinal cord (Figures The ventral white matter remained intact in all mice.
Since the total amount of BDA-labeled CST axons3J and 3K).
The ultrastructure of optic nerve myelin as seen by varied from animal to animal, the number of corticofugal
fibers was determined in the medulla oblongata rostralconventional transmission electron microscopy revealed
no differences in compactness or layering of the myelin to the pyramidal decussation, and counts of sprouting
and regenerating fibers were related either to this num-sheaths of the Nogo-A KO mice compared to their wild-
type littermates (Figures 3E and 3F). Likewise, ultra- ber of total traced fibers in each mouse (Figures 4A–4D)
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Figure 4. Quantification of Growing Fibers in the Spinal Cord
(I) Schematic drawing showing a sagittal section of the lesioned spinal cord and the different levels from the lesion center where intersecting
BDA-labeled fibers were counted.
(II) Scheme of cross-section demonstrating the selection of medial and lateral sections of the sagittal series where quantification was performed.
(A–D) Scatter graphs showing the number of counted fibers per total corticofugal fibers per section for each animal, wild-type (n  12) (filled
squares), KO (n  16) (open circles). Bars representing the mean values of sprouting fibers of 5–7 medial and 1–3 lateral sections per group.
*p  0.001 (Mann-Whitney U test for post hoc comparison). ml, middle of lesion; (ml  CST end/2), half distance between end of CST and
middle of lesion.
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or to the number of fibers in the gray matter 0.5 mm tissues, indicating that in these tissues Nogo-A/B is reg-
ulated differently compared to oligodendrocytes.rostral to the CST end (Figure 4E).
To determine the effect of the Nogo-A deletion on Immunohistochemistry of brain and spinal cord sec-
tions did not reveal qualitative differences in the stainingsprouting of collaterals and regeneration of injured fibers
toward the lesion, several levels rostral from the lesion patterns for MBP, MAG, chondroitin sulfate proteogly-
cans, GFAP, or activated macrophages/microglia. Theepicenter were quantitatively analyzed by counting all
fibers that intersected with a vertical test line positioned brain anatomy of the Nogo-A KOs appeared normal, and
the ultrastructure of myelin revealed no major changesover sagittal sections of the mid thoracic spinal cord
(Figure 4I). To account for differences in fiber growth on in layering or compactness in Nogo-A KO myelin. The
mice were fertile, and in gross behavioral tests no differ-medial or lateral tissue bridges, the medial plain with
the main CST was analyzed separately from the lateral ences between wild-types and KOs were detected.
These results indicate that, in spite of the specific ex-gray matter region (Figure 4II). The most lateral white
matter rim with the few, often intact fibers of the dorso- pression of Nogo-A in subtypes of developing and adult
neurons and in oligodendrocytes (Huber et al., 2002;lateral CST was excluded from the analysis. In wild-type
animals, the number of sprouting collaterals at 0.5 mm Wang et al., 2002b), its absence is tolerated or can be
compensated in conventional KO mice. Conditional KOrostral to the end of the CST was increased as compared
to the Nogo-A KO mice (medial, 2  7.02, p  0.008) mice, in which Nogo expression can be switched off at
defined stages, e.g., in the adult, will probably give a(Figure 4A). In contrast, significantly more fibers could
be seen to grow from the end of the main cut CST toward clearer answer as to the essential roles of Nogo-A in
the adult or developing CNS.and into the lesion in the Nogo-A KO mice (2  4.92,
p 0.03), especially over the lateral tissue bridges, thus The inhibitory activity of spinal cord extracts from KO
mice was compared to that of wild-types for neuriteavoiding the scar and debris area of the lesion center
(Figure 4C). Regenerating fibers, with typical irregular outgrowth. The Nogo-A-deficient spinal cord was clearly
less inhibitory than the wild-type tissue, interestingly towinding growth (Figures 5A and 5B), were frequent in
tissue bridges at the level of the lesion in 4 of 16 KO the same extent as a wild-type substrate in the presence
of a Nogo-A-specific antibody. The high levels ofmice; very few fibers were also present in 3 of 12 of the
wild-type mice (Figure 4D). Nogo-B in spinal cord oligodendrocytes of KO mice may
still contribute to inhibitory activity of KO myelin forAssessment of fibers caudal to the lesion revealed
more fibers with irregular winding course and profuse growing neurites through the Nogo-66 aa inhibitory se-
quence that is present in Nogo-A and -B and can exertarborizations in the gray matter regions of KO mice than
in wild-type mice (Figures 5C–5F). Some of these fibers neurite growth inhibitory activity in vitro and in vivo
(Fournier et al., 2001).could be followed around the lesion up to the transected
CST. Their irregular course is compatible with them be- To quantitatively analyze the effects of a systemic
and chronic ablation of Nogo-A on lesioned axons, weing regenerated CST axons (Figures 5I and 5J). Such
fibers were much less frequent in wild-type mice (Fig- established a reproducible and observer-independent
counting method for a randomized evaluation of fibers inures 5G and 5H). Quantification showed large variability
among the animals, but a clear subpopulation of KO the lesioned spinal cord. The results show that following
dorsal transection lesions of the adult spinal cord, plas-mice with high CST fiber numbers in the spinal cord
caudal to the lesion (Figure 4E). In addition, most animals tic and regenerative processes in Nogo-A ablated mice
are improved compared to wild-type littermates. Thehad a few spared CST fibers in the ventral or lateral
funiculi. These fibers may also contribute to the pool of most robust effect was observed in short-distance re-
generating fibers, growing from the end of the com-labeled fibers found caudal to the lesion in both groups
of animals, and their sprouting may be increased in the pletely severed main CST toward and into the lesion
site. These growing fibers used lateral bridges of intactNogo-A KO animals.
tissue as a substrate but avoided the scar and debris
area of the lesion epicenter, in line with the known non-Discussion
permissive properties of lesion scars in the spinal cord
(Fitch and Silver, 1997; Bradbury et al., 2002).The introduction of the nogo-A KO construct into the
mouse genome abolished nogo-A but not nogo-B or -C Nogo-A wild-type mice showed more collaterals of
the main CST rostral to the lesion site than their KOexpression. RT-PCR and Western blotting showed no
significant changes in the expression of Nogo-C or the littermates. Spontaneous, lesion-induced sprouting is
known to occur in many CNS fiber tracts, including therelated proteins of the Reticulon family Rtn1, 2, or 3.
Nogo-B, however, was upregulated about 10-fold both CST. We presume that collateral numbers rostral to the
lesion may be less in the Nogo-A KO animals due to anin the nogo KO and heterozygous mice. This upregula-
tion was observed only in CNS tissues, and immunohis- enhanced growth of regenerative sprouts from the cut
ends of the CST fibers.tochemical analysis indicated that the upregulation
mainly occurred in oligodendrocytes. No upregulation of Analysis of CST fibers in gray matter regions caudal
to the lesion site showed a mixture of regenerating asNogo-B was seen in the sciatic nerve or in nonneuronal
(E) Ratio of the number of fibers caudal to the lesion (counted at 0.5, 2, and 5 mm; counts are pooled due to the high variability on each level)
divided by the number of gray matter fibers at level A (0.5 mm rostral to the lesion). Several of the wild-type and KO mice with a value of 0
have large lesions with scars that prevented fiber growth beyond the lesion.
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Figure 5. Sprouting and Regenerating CST Fibers in the Lesioned Spinal Cord
(A and B) Growing fibers out of the main CST are characterized by an irregular winding course and often large, complex growth cones
(arrowheads, inserts). In the rostral sprouting zone, they are present in wild-type (A) as well as in Nogo-A KO mice (B). Scale bars equal 83
m and 21 m in inserts.
(C–F) Fibers of the CST at 10 mm distal to the lesion site in animals with intact (C, wt; E, KO) or severed (D and F) dorsolateral funiculus. Note
the irregular winding of fibers in the lateral gray matter regions, with simple, tip-like growth cones (arrows) and the profuse arborization pattern
(arrowheads), particularly in animals with an intact dorsolateral CST (C and E). Arborizations are clearly more pronounced in the Nogo-A KO
mice (E and F). Scale bar equals 42 m in (C)–(F).
(G–J) Camera lucida projection of complete series of consecutive parasagittal sections of the gray matter of the left side of the thoracic spinal
cord, including the lesion site and the higher lumbar spinal cord of two wild-type (G and H) and two Nogo-A KO (I and J) mice. Fibers cross
the lesion on lateral or ventral tissue bridges; their course is very irregular and winding. Scale bar equals 0.5 mm.
well as arborization of spared, mostly dorsolateral CST in Nogo-A KO mice. Compensatory sprouting of intact
fibers was shown to be enhanced in the brain stem andfibers. Quantitative observations and reconstructive
drawings revealed that such fibers were more abundant spinal cord of lesioned rats by the antibody IN-1 and
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kit (GIBCO-BRL), and thereafter PCR was performed using AmpliTaqwas paralleled by a high degree of functional recovery
Gold (Applied Biosystems). The 5	 and 3	 primers were chosen from(Raineteau et al., 2001; Thallmair et al., 1998). In addition
different exons. The sequences of the primers are available uponto enhancing the regeneration of lesioned fibers, the
request.
absence of Nogo-A may also enhance collateral sprout-
ing of intact nerve fibers.
Immunoblotting and Immunohistochemistry of MouseNogo-A has two domains with neurite growth inhibi-
Tissue and Oligodendrocytestory activity: a Nogo-A-specific domain (T. Oertle et al.,
Anti-Nogo antisera and antibodies were raised against the Nogo-2001, Soc. Neurosci., abstract; Prinjha et al., 2000; Four-
A-specific part (AS 472, monoclonal antibody 11C7) or against the
nier et al., 2001) and the Nogo-66 domain, which is Nogo-A/B common N terminus (AS Bianca) as described (Chen et al.,
common to Nogo-A, -B, and -C. The upregulation of 2000; Huber et al., 2002). For immunohistochemistry, the antibodies
were diluted in 1% normal goat serum in PBS as follows: AS Bianca,Nogo-B in our Nogo-A KOs may, therefore, affect and
1:2000; AS 472, 1:2000; mAb anti-myelin-associated glycoproteinattenuate the Nogo-A KO effects on axon growth in the
(MAG), 1:10 (clone D3A2G5); AS anti-myelin-basic protein (MBP),lesioned spinal cord. Indeed, as shown in an accompa-
1:500 (Chemicon International); mAb anti-chondroitin sulfate proteo-nying paper in this issue of Neuron (Kim et al., 2003), a
glycan (CS-56), 1:200 (Sigma); AS anti-glial fibrillary acidic protein
Nogo-A/B KO mouse showed a qualitatively similar, but (GFAP) (Dako), 1:2000; rat mAb anti-CD68 (FA/11) (Rabinowitz and
quantitatively more pronounced regeneration effect in Gordon, 1991), 1:40; mAb anti-2	,3	-cyclic nucleotide 3	-phosphohy-
drolase (CNPase) (Sigma), 1:50. For immunostaining of oligodendro-the spinal cord following partial cord transection. The
cyte cultures, the antibodies were diluted in PBS as follows: affinity-enhanced axon growth in Nogo-A KO mice is in contrast
purified AS Bianca, 1:300, rabbit anti galactocerebroside C (GalC)to the small or absent effect on regeneration enhance-
(Sommer and Schachner, 1981), 1:200 (Chemicon International); andment seen in MAG KO mice (Bartsch et al., 1995; Li et
hybridoma culture supernatants containing mAbs for O4 (1:20)
al., 1996). A major caveat is, however, highlighted by (Sommer and Schachner, 1981), MAG (clone D3A2G5), and MOG (8-
the fact that in a third, independent Nogo KO study in 18C5) were used. For Western blots, AS Bianca was diluted 1:5000 in
10 mM Tris-HCl (pH 7.4), 0.9% NaCl, 0.05 % Tween 20.this issue of Neuron (Zheng et al., 2003), in which Nogo-
For immunoblotting, proteins were isolated from fresh frozen tis-A/B was knocked out, no improvement of regeneration
sues using peqGold TriFastTM reagent (peqlab Biotechnologie, Ger-after spinal cord lesion was found. All three Nogo KO
many), or the tissues were homogenizied in extraction buffer (100studies as well as the earlier MAG KO papers are based
mM Tris-HCl [pH 7.6], 150 mM NaCl, 1 mM EDTA, 1% Non-idet
on chimeric mice with unknown proportions of genetic P40, 0.1% Na-deoxycholate, 1 mM PMSF, plus a protease inhibitor
background coming from two different mouse strains cocktail [Roche]) and centrifuged at 12,000 rpm for 10 min at 4
C.
The protein concentration of the supernatants was measured using(C57 bl/6 and S 129 for the Nogo studies). Mouse strains
Advanced Protein Assay Reagent (Cytoskeleton). Proteins were sep-are known to differ massively in many biological proper-
arated on 6%–15% gradient SDS polyacrylamide gels and blottedties from scar formation after spinal cord lesion (Steward
onto Immobilon-P membrane (Millipore). Blots were incubated firstet al., 1999) to behavior (Wolfer et al., 2002). Future
with primary antibodies, then with horseradish peroxidase-conju-
experiments with double KOs and conditional KOs will gated anti-rabbit IgG (1:20,000) (Pierce Biotechnology) and visual-
help to define the individual roles of neurite growth- ized using an enhanced chemiluminescence kit (Pierce Biotech-
nology).inhibitory constituents of the adult CNS as well as their
Immunohistochemical detection of Nogo-A, Nogo-B, other myelininterplay and concerted actions.
proteins, and glial markers was performed on 4% paraformaldehyde
(PFA) perfusion-fixed spinal cord and brain tissue derived from the
Experimental Procedures animals of the lesion experiments. Due to the sensitivity of the myelin
proteins to fixation and permeabilization, different treatment sched-
Generation of Knockout Mice and Genotyping ules were developed (Huber et al., 2002). In brief, for confocal laser
BAC 205 from strain 129CJ7 contains a 15 kb fragment covering scanning microscopy, 20 m serial cryostate sections were post-
nogo exons 2 and 3, the intervening intron, 3.9 kb of intron 2, and treated for 20 min either with ethanol/acetic acid (95%/5%) (MBP)
7.9 kb of intron 4. It was isolated from a 129 BAC library (Research or Kryofix (Merck) (MAG, Nogo-A, GFAP, FA/11), or for 30 s in20
C
Genetics) and used as a template in PCR to obtain the short and methanol (CNPase-Nogo double labeling) or without posttreatment
long arms for the KO construct. The PGK-neo gene was inserted (CS-56) and then incubated with the primary antibodies overnight
between the nogo sequences, and the Diphtheria toxin A gene was at 4
C. Signals were detected using FITC- or TRITC-conjugated goat
put to the 3	 end of the construct for selection against random or rabbit anti-mouse, anti-rat, or anti-rabbit secondary antibodies
integrants (Figure 1B). The resulting construct was electroporated (Jackson ImmunoResearch) and analyzed using a Zeiss LSM 410
into TC-1 embryonic stem (ES) cells (Deng et al., 1995), which were microscope.
screened with PCR. Targeted ES cell clones were injected into Oligodendrocyte-enriched glial cell cultures were obtained from
C57BL/6 blastocysts with subsequent implantation into foster moth- P1 pups of C57BL/6 (n  6) and Nogo-A KO (n  6) mice according
ers. The chimeras were bred with C57BL/6 mice and heterozygous to a modified protocol described earlier (van der Haar et al., 1998;
nogo/ offspring were identified. The heterozygous mice were Werner et al., 2001). Briefly, the brains were removed, stripped from
mated with both C57BL/6 and 129/SvJ mice to get the nogo KO the meninges, and cut into small pieces in prewarmed Hanks solu-
construct in two different genetic backgrounds. For the behavioral tion. Tissue fragments were incubated in trypsin (6 min at 37
C)
and regeneration tests, the F2 and F3 C57BL/6 and 129/SvJ nogo/ (GIBCO Invitrogen) and centrifuged (6 min at 1000 rpm). The re-
mice were mated to get littermates with similar genetic back- maining cell pellet was triturated with a 10 ml pipette for 10–15 times
grounds. Genotyping of the offspring was done with different PCRs in 10 ml Basal Medium (BME, GIBCO Invitrogen) with 10% horse
(Figure 1B). Assembly of the KO construct and the sequences of serum (BMEHS). The cell suspension was filtrated with a nylon cell
the PCR primers used for cloning and screening are available upon sieve (40 m2 pore size) (Beckton Dickinson), diluted in 40 ml
request. All animal experiments were approved by the Cantonal BMEHS, and plated in four 75 cm2 flasks. Microglial cells were re-
Veterinary Office in Zurich. moved after 1 week in culture (30 min shaking at 100 rpm, 37
C).
The oligodendrocyte progenitors were released from the astrocyte
monolayer by shaking the flasks overnight at 180 rpm, 37
C, centri-RT-PCR
Total RNA was isolated from flash-frozen tissues using peqGold fuged (6 min at 1000 rpm), and the cells in the pellet were grown
on poly-L-lysine-coated coverslips in differentiation medium (vanTriFastTM reagent (peqlab Biotechnologie). PCR was performed ei-
ther using the Titan One-Tube RT-PCR Kit (Roche), or cDNA was der Haar et al., 1998) with 1% horse serum. Three-day-old cultures
were washed in Dulbecco’s modified Eagle’s medium (DMEM) andprepared after DNase I (Roche) treatment using SuperscriptTM II RT
Neuron
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fixed in 4% PFA in PBS for 5 min at room temperature. Then cells The number of sprouting fibers of the dorsomedial CST around
the lesion site was analyzed quantitatively using a light microscopewere incubated with primary antibodies and FITC-conjugated goat
anti-mouse or goat anti-rabbit antibodies (Jackson ImmunoRe- with bright-field illumination. On sagittal sections, the number of
intersections of BDA-labeled fibers with a dorsoventral line posi-search), washed in PBS, mounted on slides, and coverslipped with
Mowiol (Calbiochem) and analyzed using a Zeiss Axiophot fluores- tioned at defined distances rostral from the middle of the lesion was
counted at a final magnification of 400 (Figure 4I). Fibers werecence microscope.
counted on 5–7 adjacent sections including the complete fiber tract
of the dorsomedial CST, and on 1–3 subsequent lateral sectionsUltrastructural Analysis
including mostly the arborization areas of the dorsomedial CSTMice were deeply anaesthetized with pentobarbital (Nembutal, 75
fibers in the gray matter (Figure 4II). The obtained sum of fibers wasmg/100 g body weight, Abbott Laboratories) and perfused through
normalized for interindividual tracing variability by relating it to thethe left ventricle with Ringer’s solution followed by 2% glutaralde-
total number of BDA-positive corticofugal fibers (determined in sixhyde and 2% PFA in 0.1 M sodium phosphate buffer (pH 7.6), supple-
cross-sections of the medulla oblongata rostral the pyramidal de-mented with 2 mM CaCl2. Optic nerves were dissected and placed
cussation) for each animal. Finally, this value was divided by thein fresh fixative for 3 hr and cacodylate buffer overnight at 4
C.
number of evaluated sections, resulting in the number of countedTissues were postfixed in 2% OsO4 for 2 hr, serially dehydrated,
CST fibers per total labeled corticofugal fibers per section. Theand embedded in Epon. Semithin sections were stained with tolu-
entire evaluation was performed on number-coded, randomly mixedidine blue and viewed under an Olympus microscope. Ultrathin sec-
animals, i.e., without knowing the genotype of the animals. Statisti-tions (90 nm) were analyzed using a Zeiss EM 902.
cal comparison was done with the nonparametric Kruskal-Wallis
ANOVA, using the Mann-Whitney U test for post hoc comparison.Neurite Outgrowth Assay
To analyze regenerating fibers caudal to the lesion, intersectionAdult, freshly dissected spinal cords of wt and KO mice were homog-
counts were done at 0.5, 2, and 5 mm caudal to the lesion midlineenized with CHAPS; a membrane protein extract as described by
(Figure 4I). The sum of these counts was divided by the number ofSpillmann et al. (1998) was adsorbed overnight at 15 g protein
gray matter fibers at 0.5 mm rostral to the lesion for each animalper cm2 culture dish on Greiner 4-well dishes (Greiner, Nu¨rtingen,
(Figure 4E).Germany). Dishes were washed three times with warm Hank’s solu-
tion before plating the neurons. For antibody experiments, the Fab
Acknowledgmentsfragment of the monoclonal antibody 11C7 (directed against the
same 18 aa peptide as the AS472; Chen et al., 2000) or a control
We thank Barbara Niedero¨st, Brigitte Haudenschild, Regula Schnei-mouse Fab were preincubated on the dishes at 1 g/ml for 30
der, and Jeannette Scholl for excellent technical assistance. Thismin and subsequently removed. Postnatal day (P) 6 rat cerebellar
work was supported by the Swiss National Science Foundationgranule cells were prepared as described by Niedero¨st et al. (1999)
(Grant 31-63633.00), the NCCR “Neural Plasticity and Repair,” theand plated at 50,000 cells/cm2. Cells were cultured for 24 hr in
Christopher Reeve Paralysis Foundation (Spinal Cord Consortium,serum-free medium, fixed, and immunostained for MAB 1b (Chemi-
Springfield, NJ), and the Deutsche Forschungsgemeinschaft (Grantcon monoclonal Ab, 1:200; Gordon-Weeks and Fischer, 2000). Four
PE 860/1 to V.P.).fields at a defined distance to the edge of the well were randomly
sampled for each well using a 40 objective by counting all intersec-
Received: October 23, 2002tions of neurites with a line placed through the center of the observa-
Revised: February 19, 2003tion field. All cell bodies touching the line were also counted, and
Accepted: March 18, 2003an index ratio of neurites per cell body was calculated for each well.
Published: April 23, 2003All counts were done blindly on coded experiments. Data shown in
Figure 3G are from four experiments.
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